Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1985 1
1990 1
1996 1
1997 2
1998 1
2000 1
2002 3
2003 7
2004 3
2005 5
2006 6
2007 6
2008 4
2009 10
2010 3
2011 3
2012 6
2013 7
2014 4
2015 8
2016 8
2017 11
2018 9
2019 6
2020 12
2021 11
2022 13
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Lorenzen S, Götze TO, Thuss-Patience P, Biebl M, Homann N, Schenk M, Lindig U, Heuer V, Kretzschmar A, Goekkurt E, Haag GM, Riera-Knorrenschild J, Bolling C, Hofheinz RD, Zhan T, Angermeier S, Ettrich TJ, Siebenhuener AR, Elshafei M, Bechstein WO, Gaiser T, Loose M, Sookthai D, Kopp C, Pauligk C, Al-Batran SE; AIO and SAKK Study Working Groups. Lorenzen S, et al. Among authors: kretzschmar a. J Clin Oncol. 2024 Feb 1;42(4):410-420. doi: 10.1200/JCO.23.00975. Epub 2023 Nov 14. J Clin Oncol. 2024. PMID: 37963317 Clinical Trial.
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
Modest DP, Karthaus M, Fruehauf S, Graeven U, Müller L, König AO, Fischer von Weikersthal L, Caca K, Kretzschmar A, Goekkurt E, Haas S, Kurreck A, Stahler A, Held S, Jarosch A, Horst D, Reinacher-Schick A, Kasper S, Heinemann V, Stintzing S, Trarbach T. Modest DP, et al. Among authors: kretzschmar a. J Clin Oncol. 2022 Jan 1;40(1):72-82. doi: 10.1200/JCO.21.01332. Epub 2021 Sep 17. J Clin Oncol. 2022. PMID: 34533973 Free PMC article. Clinical Trial.
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
Stein A, Paschold L, Tintelnot J, Goekkurt E, Henkes SS, Simnica D, Schultheiss C, Willscher E, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich T, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Sinn M, Lindig U, Hiegl W, Hinke A, Hegewisch-Becker S, Binder M. Stein A, et al. Among authors: kretzschmar a. JAMA Oncol. 2022 Aug 1;8(8):1150-1158. doi: 10.1001/jamaoncol.2022.2228. JAMA Oncol. 2022. PMID: 35737383 Free PMC article. Clinical Trial.
VTE-Prophylaxe bei Niereninsuffizienz.
Kretzschmar A. Kretzschmar A. Hamostaseologie. 2018 Feb;38(1):54. doi: 10.1055/s-0038-1637802. Epub 2018 Mar 1. Hamostaseologie. 2018. PMID: 29536482 German. No abstract available.
Character strengths and fluid intelligence.
Kretzschmar A, Wagner L, Gander F, Hofmann J, Proyer RT, Ruch W. Kretzschmar A, et al. J Pers. 2022 Dec;90(6):1057-1069. doi: 10.1111/jopy.12715. Epub 2022 Apr 8. J Pers. 2022. PMID: 35303763 Free PMC article.
Self-Esteem and Income Over Time.
Bleidorn W, Kretzschmar A, Rauthmann JF, Orth U, Denissen JJA, Hopwood CJ. Bleidorn W, et al. Among authors: kretzschmar a. Psychol Sci. 2023 Oct;34(10):1163-1172. doi: 10.1177/09567976231185129. Epub 2023 Sep 21. Psychol Sci. 2023. PMID: 37732970 Free article.
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
Hofheinz RD, Merx K, Haag GM, Springfeld C, Ettrich T, Borchert K, Kretzschmar A, Teschendorf C, Siegler G, Ebert MP, Goekkurt E, Mahlberg R, Homann N, Pink D, Bechstein W, Reichardt P, Flach H, Gaiser T, Battmann A, Oduncu FS, Loose M, Sookthai D, Pauligk C, Göetze TO, Al-Batran SE. Hofheinz RD, et al. Among authors: kretzschmar a. J Clin Oncol. 2022 Nov 10;40(32):3750-3761. doi: 10.1200/JCO.22.00380. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709415 Clinical Trial.
Extravasations of oxaliplatin.
Kretzschmar A, Pink D, Thuss-Patience P, Dörken B, Reichert P, Eckert R. Kretzschmar A, et al. J Clin Oncol. 2003 Nov 1;21(21):4068-9. doi: 10.1200/JCO.2003.99.095. J Clin Oncol. 2003. PMID: 14581435 No abstract available.
Characterizing Human Habits in the Lab.
Nebe S, Kretzschmar A, Brandt MC, Tobler PN. Nebe S, et al. Among authors: kretzschmar a. Collabra Psychol. 2024 Feb 28;10(1):92949. doi: 10.1525/collabra.92949. Collabra Psychol. 2024. PMID: 38463460 Free PMC article.
Evolution of vault RNAs.
Stadler PF, Chen JJ, Hackermüller J, Hoffmann S, Horn F, Khaitovich P, Kretzschmar AK, Mosig A, Prohaska SJ, Qi X, Schutt K, Ullmann K. Stadler PF, et al. Among authors: kretzschmar ak. Mol Biol Evol. 2009 Sep;26(9):1975-91. doi: 10.1093/molbev/msp112. Epub 2009 Jun 2. Mol Biol Evol. 2009. PMID: 19491402
146 results